Beam Therapeutics Ownership & Insider Activity

Beam Therapeutics (BEAM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.6% of shares outstanding. Institutional investors hold 79.3%. Over the past 90 days, insiders made 1 sale worth $5K.

Shares Outstanding

102.879M

Shares Float

66.399M

Insider Shares Owned

1.669M

Insider % Owned

1.6%

Institutional Shares Held

81.954M

Institutional % Held

79.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$5K total

Net Activity

Net Selling

Net Value (90d)

-$5K

Beam Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 15, 2026	John Evans	CEO	SELL-OPTIONS	—	$12.40	$1.1M
Oct 1, 2026	Bethany Cavanagh	SVP, FINANCE AND TREASURER	SELL	187.000	$24.41	$5K
Jul 27, 2026	Amy Simon	CHIEF MEDICAL OFFICER	SELL	16.667K	$25.74	$429K
Jun 30, 2026	Amy Simon	CHIEF MEDICAL OFFICER	SELL	373.000	$34.73	$13K
Jun 29, 2026	John Evans	CEO	SELL-OPTIONS	—	$17.90	$1.7M
Jun 25, 2026	FMR LLC	—	SELL	284.860K	$35.24	$10.0M